Table 3.
Model 1, adjusted risks for metabolic syndrome (MetS), conventionally, individual MetS-components are not separated apart
| Baseline potential risk factors* | Adjusted-OR** | 95%CI | p |
|---|---|---|---|
| MetS component | |||
| COB | 7.5 | 4.0 - 14.2 | <0.01 |
| Hyper-TG | 2.4 | 1.5 - 3.7 | <0.01 |
| Hyper-GL | 2.2 | 1.4 - 3.3 | <0.01 |
| Low-HDL | 2.7 | 1.8 - 4.0 | <0.01 |
| HBP | 2.5 | 1.6 - 3.9 | <0.01 |
| Hyperuricemia | 1.0 | 0.6 - 1.6 | 0.98 |
| Sonographic fatty liver | 2.3 | 1.6 - 3.5 | <0.01 |
| Elevated alanine aminotransferase | 1.3 | 0.8 - 2.1 | 0.36 |
| Elevated γ-glutamil transferase | 2.0 | 1.3 - 3.1 | <0.01 |
| Hyperinsulinemia | 1.7 | 1.1 - 2.6 | <0.01 |
* Abbreviations: Hyper-GL, hyperglycemia; Low-HDL, Low-HDL cholesterolemia; HBP, High blood pressure; Hyper-TG, hypertriglyceridemia; COB, central obesity
** Adjusted variables were age and categorical variables including gender, smoking, diet habits, drinking, exercise status, sonographic liver enzymes, fatty liver, hepatovirus infections, hyperinsulinemia and hyperuricemia.